Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Hawryluk currently holds 11,727 shares of Predictive Oncology Inc. (POAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Hawryluk has been a net seller of POAI stock. They have purchased $0 and sold $6.9K worth of shares.
Matthew Hawryluk's most recent insider trade was on Apr 20, 2026, when they sold 6,782 shares at $0.00 per share.
Matthew Hawryluk serves as Executive at Predictive Oncology Inc. (POAI). They have executed 16 insider transactions totaling $6.9K over their tenure at the company.
Matthew Hawryluk holds the position of Executive at Predictive Oncology Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Matthew Hawryluk has shown a selling trading pattern, with $0 in total purchases and $6.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew Hawryluk was on May 16, 2024, when they sold $6.9K worth of GRTS shares. This transaction involved 9,259 shares at $0.75 per share.
Matthew Hawryluk currently owns 11,727 shares of Predictive Oncology Inc. (POAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Hawryluk's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Hawryluk has 16 Form 4 filings on record as an insider at Predictive Oncology Inc..
Set alerts for Matthew Hawryluk and 40,000+ other insiders.